-
IntroducedJan 21, 2026
-
Passed House
-
Passed Senate
-
Became Law
Rhode Island House Bill
AN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT (Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.)
Last Action See all actions
House • Feb 03, 2026: 02/03/2026 Committee recommended measure be held for further study
Latest Bill Text See all bill texts
Summary
Comments on HB 7187
Tweets
Whip Lists
Sponsors
Votes
Actions
- Feb 03, 2026 | House
- 02/03/2026 Committee recommended measure be held for further study
- Jan 30, 2026 | House
- 01/30/2026 Scheduled for hearing and/or consideration (02/03/2026)
- Jan 21, 2026 | House
- 01/21/2026 Introduced, referred to House Health & Human Services
Bill Texts
Documents
- 01/30/2026 Scheduled for hearing and/or consideration (02/03/2026)
- House Health and Human Services: 02-03-2026--H7187--Sarah Lynn_Geiger (AHIP)--HHSPDF
- House Health and Human Services: 02-03-2026--H7187--Sam_Hallemeier (PCMA)--HHSPDF
- House Health and Human Services: 02-03-2026--H7187--Richard_Glucksman (Blue Cross Blue Shield)--HHSPDF
- House Health and Human Services: 02-03-2026--H7187--Haley_McKee--HHSPDF
- House Health and Human Services: 02-03-2026--H7187--Elisabeth_Hubbard (Governors Commission on Disibilities)--HHSPDF
- House Health and Human Services: 02-03-2026--H7187--Cory_King (Health Insurance Commissioner)--HHSPDF
- House Health and Human Services: 02-03-2026--H7187, H7275, H7277--Jason_Martiesian (RIBC)--HHSPDF



